You have 9 free searches left this month | for more free features.

necrosis inhibitor

Showing 1 - 25 of 9,074

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in

Completed
  • Psoriatic Arthritis
  • No Intervention
  • Brussels, Belgium
  • +67 more
Jun 18, 2021

Serious Infections in Rheumatoid Arthritis Patients Receiving

Active, not recruiting
  • Infection
  • Rheumatoid Arthritis
  • Tocilizumab
  • Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab)
  • Suwon, Gyeonggi-do, Korea, Republic of
    Sungkyunkwan University
Sep 8, 2020

Brain Tumor, Brain Metastases, Brain Cancer Trial in Indianapolis, Portland (Reduced Dose SRS)

Recruiting
  • Brain Tumor
  • +2 more
  • Reduced Dose SRS
  • Indianapolis, Indiana
  • +2 more
Aug 29, 2022

Melanoma Metastatic in the Brain Trial in Gainesville (CA-4948, Pembrolizumab)

Not yet recruiting
  • Melanoma Metastatic in the Brain
  • Gainesville, Florida
    University of Florida
Dec 20, 2022

Spinal Stenosis Trial (Epidural Intervention with TNF-a inhibitor)

Completed
  • Spinal Stenosis
  • Epidural Intervention with TNF-α inhibitor
  • (no location specified)
Aug 19, 2019

Osteosarcoma Trial (Surufatinib plus chemo, Chemotherapy)

Not yet recruiting
  • Osteosarcoma
  • (no location specified)
Jun 29, 2023

Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • London, Ontario, Canada
    Rheumatology Clinic, St. Joseph's Health Care
May 10, 2022

Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • Inflammation
  • (no location specified)
Nov 21, 2023

TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer

Completed
  • Rheumatoid Arthritis
  • Boston, Massachusetts
    Brigham And Women's Hospital
Jun 17, 2022

Periarticular Bone Structure in Patients Treated With Either

Completed
  • Rheumatoid Arthritis
  • Erlangen, Germany
    University Erlangen-Nuremberg, Medical Department 3, Rheumatolog
Sep 25, 2019

Noninterventional Examination of Subcutaneous Tumor Necrosis

Completed
  • Rheumatoid Arthritis
    • Aachen, Germany
    • +121 more
    Dec 21, 2020

    Rheumatoid Arthritis Trial in Worldwide (Olokizumab, Placebo)

    Completed
    • Rheumatoid Arthritis
    • Glendale, Arizona
    • +164 more
    Jun 30, 2021

    TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular

    Completed
    • Rheumatoid Arthritis
    • Boston, Massachusetts
      Brigham And Women's Hospital
    Mar 1, 2022

    Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Tadalafil 20Mg Oral Tablet
    • Pentoxifylline 400 MG Oral Tablet
    • (no location specified)
    Aug 2, 2022

    Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

    Recruiting
    • Arthritis, Rheumatoid
    • +2 more
      • Aalborg, Denmark
        Department of rheumatology
      Sep 1, 2022

      Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)

      Not yet recruiting
      • Thrombocytopenia, Immune
      • Heparin Induced Thrombocytopenia
      • (no location specified)
      Mar 24, 2023

      Lung Transplant; Complications Trial in Chicago (Etanercept Injection [Enbrel])

      Enrolling by invitation
      • Lung Transplant; Complications
      • Etanercept Injection [Enbrel]
      • Chicago, Illinois
        Northwestern University
      Jul 10, 2023

      Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +

      Recruiting
      • Myocardial Infarction
      • +2 more
      • P2Y12 Potent Inhibitor + Aspirin for STEMI patients
      • Clopidogrel + Aspirin for CCS patients
      • Messina, Italy
        AOU Policlinico G. Martino
      Jan 21, 2023

      Anti-citrullinated Protein Antibody Status on Treatment Response

      Completed
      • Rheumatoid Arthritis
      • Non-Interventional
      • Canberra City, Australia
        (unnamed)
      Feb 22, 2022

      Psoriasis Trial (Roflumilast, Methotrexate)

      Not yet recruiting
      • Psoriasis
      • (no location specified)
      Jan 5, 2023

      MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)

      Recruiting
      • Major Depressive Disorder
      • Sildenafil Citrate
      • Placebo oral tablet
      • Shibīn Al Kawm, Egypt
        Faculty of Medicine
      Jan 16, 2023

      Hepatocellular Carcinoma, Gastric Cancer Trial in Orange (Nivolumab Injectable Product, Trans-arterial tirapazamine

      Recruiting
      • Hepatocellular Carcinoma
      • Gastric Cancer
      • Nivolumab Injectable Product
      • Trans-arterial tirapazamine embolization
      • Orange, California
        University of California, Irvine
      Apr 13, 2022

      Rheumatoid Arthritis Trial in Shibin Al Kawm (Paroxetine, Placebo)

      Recruiting
      • Rheumatoid Arthritis
      • Shibīn Al Kawm, Menoufia, Egypt
        Faculty of Pharmacy
      Jan 16, 2023